Marc Goodman
Stock Analyst at Leerink Partners
(2.65)
# 613
Out of 5,270 analysts
140
Total ratings
60.61%
Success rate
31.07%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Axsome Therapeutics | Maintains: Outperform | 110 150 | 127.09 | 18.03% | 7 | Feb 10, 2025 | |
Relmada Therapeutics | Downgrades: Market Perform | 10 1 | 0.26 | 284.62% | 3 | Dec 4, 2024 | |
Biohaven | Maintains: Outperform | 55 60 | 31.93 | 87.91% | 6 | Sep 23, 2024 | |
LENZ Therapeutics | Initiates Coverage On: Outperform | 32 | 21.49 | 48.91% | 1 | Apr 15, 2024 | |
Amylyx Pharma | Downgrades: Market Perform | n/a | n/a | n/a | 4 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 25 | 57.01 | -56.15% | 1 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 1 | n/a | n/a | 5 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 15.12 | 230.69% | 1 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 27 23 | n/a | n/a | 4 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 20 | 14.35 | 39.37% | 3 | Jan 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 15 1 | n/a | n/a | 4 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 100 115 | 114.47 | 0.46% | 4 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 270 310 | 141.77 | 118.66% | 11 | Oct 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 4 | n/a | n/a | 4 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 12 | 7.54 | 59.15% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 46 | 35.7 | 28.85% | 4 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 170 270 | n/a | n/a | 2 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 27 21 | 18.14 | 15.77% | 5 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 200 210 | 140.19 | 49.8% | 5 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 50 40 | 7.21 | 454.79% | 5 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 10 | 2.4 | 316.67% | 2 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 24 27 | 34.1 | -20.82% | 5 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 25 | 5.11 | 389.24% | 1 | Apr 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 65 70 | 131.27 | -46.67% | 3 | Apr 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 10 2 | n/a | n/a | 4 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 15 | 6.12 | 145.1% | 2 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 37 32 | n/a | n/a | 3 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 322 70 | n/a | n/a | 3 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 200 220 | n/a | n/a | 1 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 300 270 | 348.84 | -22.6% | 5 | Mar 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 79 96 | 211.49 | -54.61% | 5 | Nov 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 189 203 | n/a | n/a | 5 | Nov 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 72 0 | n/a | n/a | 2 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 7 | n/a | n/a | 4 | Nov 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 12 16 | n/a | n/a | 2 | Oct 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 72 67 | 93.09 | -28.03% | 3 | Oct 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 15 | n/a | n/a | 2 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 84 98 | 28.89 | 239.22% | 3 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Mar 20, 2017 |